• OPEN AN ACCOUNT
Indian Indices
Nifty
22,147.90 -124.60
(-0.56%)
Sensex
72,943.68 -456.10
( -0.62%)
Bank Nifty
47,484.80 -288.45
( -0.60%)
Nifty IT
33,574.95 -888.65
( -2.58%)
Global Indices
Nasdaq
15,885.02 -290.07
(-1.79%)
Dow Jones
37,735.11 -248.13
(-0.65%)
Hang Seng
16,248.97 -351.49
(-2.12%)
Nikkei 225
38,471.20 -761.60
(-1.94%)
Forex
USD-INR
83.61 0.25
(0.30%)
EUR-INR
88.96 -0.50
(-0.56%)
GBP-INR
104.08 -0.51
(-0.49%)
JPY-INR
0.55 0.00
(0.15%)

EQUITY - MARKET SCREENER

KCD Industries India Ltd
Industry :  Construction
BSE Code
ISIN Demat
Book Value()
540696
INE185U01035
8.6506194
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
8.22
24.44
EPS(TTM)
Face Value()
Div & Yield %
1.18
1
0
 

sun pharmaceuticals industries ltd
Sun Pharma proposes to acquire Taro
May 27,2023
Sun Pharmaceuticals Industries on 26 May 2023 has issued a letter to the Board of Directors of Taro Pharmaceutical Industries, Israel (Taro) with a proposal containing a non-binding indication of interest to acquire all of the outstanding ordinary shares in Taro, other than any shares already held by the Company or its affiliates (For a purchase price of $38 per ordinary share) (Proposed Transaction).

The Proposed Transaction to be consummated in the form of a reverse triangular merger under the Israeli Companies Law, 1999 (ICL) and practice. In this context, Purchaser shall form a wholly owned subsidiary (SPV), which shall enter into a merger agreement with Taro, with the SPV merging with and into Taro and Taro surviving the merger transaction. Consequently, Taro shall become a wholly owned subsidiary of Purchaser and be de-listed from NYSE.